Login

Unveiling the Motivations behind Evolis' Intended Sale to HID Group | Emmanuel Picot, CEO of Evolis sa 00:10:00

Share On Facebook Share On Twitter

Emmanuel Picot is Chairman/CEO at Evolis SA.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Job Curtis: Guiding City of London Investment Trust with Strategic Stock Picks
00:10:00
Artem Volynets Talks ACG SPAC Launch and Opportunity in New Economy Metals | Artem Volynets, CEO , ACG Acquisition Company Ltd.
00:10:00
Assessing Intelligence Failures: The Case of WMDs in Iraq|James Woolsey
00:10:00
T2 Metals CEO Mark Saxon Discusses Copper Projects and Exploration Progress
00:00:00
Akers Biosciences Inc to be cash generative in second half - Raymond Akers, Executive chairman of Akers Biosciences Inc
00:10:00
Bone health and its connection to menopause explained by Liv Garfield, Chief Executive of Severn Trent Water, offering career advice.
00:10:00
Focuses on early-stage growth software and data-center investments|Ping Li,Partner,Accel
00:10:00
Mirriad Advertising CEO Stephan Beringer and SpringServe GM Joseph Hirsch join Proactive's Stephen Gunnion for a discussion.
00:10:00
Brazilian entrepreneur and VTEX co-founder Mariano Gomide brings his innovative vision and determination to pioneering the e-commerce market.
00:10:00
Canaan is a long-time early-stage investor currently investing firms|Maha Ibrahim,General Partner,Canaan Partners
00:10:00
Canadian Mining IP Workshop: Boosting Innovation and Global Competitiveness | Chamirai Charles Nyabeze, MICA Network Director of Centre for Excellence in Mining Innovation
00:10:00
Amica SA: 2022 Summary Conference Recording with Jacek Rutkowski | Jacek Rutkowski, President , Amica SA.

© 2026 Nehu